Requirement of Analgesics After Two Remifentanil Dosing Regimen in Cardiac Surgery.
NCT ID: NCT00757198
Last Updated: 2013-09-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
90 participants
INTERVENTIONAL
2008-09-30
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Remifentanil and Hyperalgesia: Gradual Withdrawal Versus Immediate Discontinuation
NCT03110653
1.Comparison of the Analgesic Effect of Remifentanil Group and Different Dose Groups of Oliceridine in Postoperative Patients Undergoing Cardiac Surgery 2.Exploring the Hemodynamic Effects of Analgesic Regimens With Different Doses of Oliceridine After Cardiac Surgery
NCT06619145
Opioids Continue to Play a Primary Role in the Management of Perioperative Pain Due to Opioid-Free Anesthesia in Open Heart Surgery.
NCT06683911
Multimodal Versus Opioid aNalgesia in carDiAc Surgery
NCT04987372
Oxycodone vs Fentanyl for Pain Treatment After Laparoscopic Cholecystectomy
NCT00369811
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
remifentanil o.1 mcg/kg/min
remifentanil
remifentanil infusion
2
remifentanil 0.3 mcg/kg/min
remifentanil
remifentanil infusion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
remifentanil
remifentanil infusion
remifentanil
remifentanil infusion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kuopio University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pasi Lahtinen
PhD,MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pasi Lahtinen, MD
Role: STUDY_DIRECTOR
Department of Anesthesiology and Intensive Care, Kuopio University hospital, Kuopio, Finland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kuopio University hospital
Kuopio, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EudraCT 2008-000597-21
Identifier Type: -
Identifier Source: secondary_id
KUH5070206
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.